News

Abbvie Com (ABBV) Holder New York State Teachers Retirement System Has Decreased Its Holding as Stock Price Declined; Third Point Raised Microsoft (MSFT) Holding by $210.90 Million; Stock Declined


AbbVie Inc. (NYSE:ABBV) Logo

Third Point Llc increased its stake in Microsoft Corp (MSFT) by 82.22% based on its latest 2018Q3 regulatory filing with the SEC. Third Point Llc bought 1.85M shares as the company’s stock declined 1.64% with the market. The hedge fund held 4.10 million shares of the prepackaged software company at the end of 2018Q3, valued at $468.92M, up from 2.25 million at the end of the previous reported quarter. Third Point Llc who had been investing in Microsoft Corp for a number of months, seems to be bullish on the $789.09B market cap company. The stock decreased 1.58% or $1.65 during the last trading session, reaching $102.78. About 35.54M shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 30.43% since February 2, 2018 and is uptrending. It has outperformed by 30.43% the S&P500. Some Historical MSFT News: 30/05/2018 – Ziften Enters Germany with Microsoft Azure-Powered Endpoint Security Solution; Partners with Microsoft Windows Defender ATP Reseller sepago; 03/05/2018 – INVIVO Communications Inc. Accepted into the Microsoft Mixed Reality Partner Program (MRPP); 07/05/2018 – Microsoft’s Cortana Faces Uphill Battle Winning Over Developers; 20/04/2018 – DGAP-NEWS: RIB AND MICROSOFT JOIN FORCES TO CREATE THE WORLD’S NO.1 VERTICAL CLOUD FOR THE CONSTRUCTION AND REAL ESTATE INDUSTRIES; 26/04/2018 – WhiteSource Launches Contextual Pattern Matching Engine, Supporting Over 200 Programming Languages; 26/04/2018 – MICROSOFT CFO SAYS APPETITE FOR M&A IS UNCHANGED; 13/03/2018 – Microsoft opens two data centres in Germany – reports; 27/03/2018 – Starr Companies Announces Agreement with SkyWatch for Aviation lnsureds; 11/04/2018 – Source-to-Pay Leader Determine, Inc. Increases Position in Top Analyst Firm Spend Matters April 2018 SolutionMap(SM) Rankings; 30/05/2018 – But former Google, Microsoft and Facebook executives say the algorithmic revolution in hiring is moving too fast

New York State Teachers Retirement System decreased its stake in Abbvie Inc Com (ABBV) by 2.58% based on its latest 2018Q3 regulatory filing with the SEC. New York State Teachers Retirement System sold 66,370 shares as the company’s stock declined 6.62% with the market. The institutional investor held 2.51M shares of the major pharmaceuticals company at the end of 2018Q3, valued at $237.37 million, down from 2.58M at the end of the previous reported quarter. New York State Teachers Retirement System who had been investing in Abbvie Inc Com for a number of months, seems to be less bullish one the $121.09 billion market cap company. The stock increased 0.26% or $0.21 during the last trading session, reaching $80.5. About 6.76 million shares traded. AbbVie Inc. (NYSE:ABBV) has declined 7.04% since February 2, 2018 and is downtrending. It has underperformed by 7.04% the S&P500. Some Historical ABBV News: 17/05/2018 – Oncolytics Biotech® Announces Collaboration with Merck and Northwestern University Combining Keytruda® and REOLYSIN® in a Phase 2 Second Line Pancreatic Cancer Study; 07/05/2018 – Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma; 06/03/2018 – ABBVIE GETS POSITIVE RECOMMENDATION FOR VENCLEXTA; 30/04/2018 – FDA Grants Priority Review to Merck’s sBLA for KEYTRUDA® (pembrolizumab) in Combination with Pemetrexed (ALIMTA®) and; 10/04/2018 – Oncolytics Biotech: Combination Therapy With REOLYSIN(R), Keytruda(R) and/or anti-CD73 Immunotherapy Led to Rejection of Pre-Established Tumors; 25/05/2018 – IMFINZI(R) (Durvalumab) Significantly Improves Overall Survival in the Phase III Pacific Trial for Unresectable Stage III Non-Small Cell Lung Cancer; 21/05/2018 – AbbVie Presenting at UBS Conference Tomorrow; 22/03/2018 – AbbVie in $25bn wipeout after cancer drug results; 23/05/2018 – MERCK & CO’S KEYTRUDA SIGNIFICANTLY IMPROVED OVERALL SURVIVAL; 07/05/2018 – JANSSEN PHARMA – FDA APPROVAL OF DARZALEX IN COMBINATION WITH BORTEZOMIB, MELPHALAN AND PREDNISONE MARKS ITS FIFTH INDICATION IN MULTIPLE MYELOMA

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “Tiny Israeli firm touts cancer cure – Seeking Alpha” on January 29, 2019, also Seekingalpha.com with their article: “AbbVie’s Existential Tests Are Upon It – Seeking Alpha” published on January 31, 2019, Seekingalpha.com published: “Hospitals squeezed by high drug costs – Seeking Alpha” on January 16, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “Biotechs lead broad market advance, XBI up 5% – Seeking Alpha” published on January 04, 2019 as well as Seekingalpha.com‘s news article titled: “U.S. IPO Week Ahead: 2 Billion-Dollar Biotechs In A 4-IPO Week – Seeking Alpha” with publication date: February 02, 2019.

New York State Teachers Retirement System, which manages about $42.67B US Long portfolio, upped its stake in Illumina Inc (NASDAQ:ILMN) by 1,100 shares to 215,614 shares, valued at $79.14M in 2018Q3, according to the filing. It also increased its holding in Bio Rad Labs (NYSE:BIO) by 1,203 shares in the quarter, for a total of 16,003 shares, and has risen its stake in Tcf Financial Corp (NYSE:TCB).

Among 26 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 3 Sell and 13 Hold. Therefore 38% are positive. Abbvie Inc had 106 analyst reports since July 21, 2015 according to SRatingsIntel. Morgan Stanley downgraded it to “Equal-Weight” rating and $65 target in Wednesday, June 8 report. The firm has “Buy” rating given on Tuesday, November 6 by Argus Research. On Thursday, September 28 the stock rating was maintained by Piper Jaffray with “Buy”. The rating was maintained by Cowen & Co with “Buy” on Monday, November 20. Jefferies maintained the shares of ABBV in report on Thursday, May 25 with “Buy” rating. Bank of America maintained it with “Buy” rating and $105 target in Monday, July 30 report. Cowen & Co maintained the shares of ABBV in report on Friday, July 28 with “Hold” rating. Deutsche Bank upgraded it to “Hold” rating and $88.0 target in Thursday, September 28 report. The rating was maintained by BMO Capital Markets with “Hold” on Sunday, July 30. The stock has “Equal-Weight” rating by Barclays Capital on Friday, October 13.

Investors sentiment decreased to 0.82 in Q3 2018. Its down 0.12, from 0.94 in 2018Q2. It dived, as 60 investors sold ABBV shares while 637 reduced holdings. 107 funds opened positions while 466 raised stakes. 994.12 million shares or 0.91% less from 1.00 billion shares in 2018Q2 were reported. Baker Avenue Asset Mngmt Lp reported 0.22% of its portfolio in AbbVie Inc. (NYSE:ABBV). State Treasurer State Of Michigan reported 0.45% in AbbVie Inc. (NYSE:ABBV). Proshare Advisors Limited Liability Corp stated it has 1.01M shares. Jefferies Fincl Group has invested 0.31% in AbbVie Inc. (NYSE:ABBV). Of Oklahoma holds 7,520 shares or 0% of its portfolio. Bokf Na holds 0.47% or 198,230 shares in its portfolio. Violich Mngmt stated it has 134,538 shares or 2.91% of all its holdings. Susquehanna Intl Grp Inc Llp holds 0% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 132,634 shares. Chase Investment Counsel Corporation holds 2,899 shares. Glovista Invests has 0.11% invested in AbbVie Inc. (NYSE:ABBV) for 4,323 shares. Horseman Mgmt Ltd holds 0.47% or 21,000 shares. 70,326 are owned by Montag A Assocs. 81,471 are held by Stonebridge Capital Advsr Ltd. Zevenbergen Ltd Liability holds 2,712 shares. Main Street Llc has invested 2.2% in AbbVie Inc. (NYSE:ABBV).

Since August 17, 2018, it had 0 insider purchases, and 6 insider sales for $26.66 million activity. 50,000 AbbVie Inc. (NYSE:ABBV) shares with value of $4.88 million were sold by SEVERINO MICHAEL. Gosebruch Henry O sold 42,450 shares worth $3.82 million. The insider GONZALEZ RICHARD A sold $1.50M. 60,000 shares were sold by CHASE WILLIAM J, worth $5.40 million.

Among 38 analysts covering Microsoft Corporation (NASDAQ:MSFT), 34 have Buy rating, 1 Sell and 3 Hold. Therefore 89% are positive. Microsoft Corporation had 217 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Microsoft Corporation (NASDAQ:MSFT) earned “Buy” rating by Raymond James on Friday, July 21. The rating was maintained by Piper Jaffray with “Overweight” on Tuesday, November 10. As per Thursday, January 25, the company rating was maintained by J.P. Morgan. On Friday, July 21 the stock rating was maintained by UBS with “Buy”. The stock has “Sell” rating by Citigroup on Friday, July 21. The firm earned “Overweight” rating on Wednesday, January 13 by Morgan Stanley. On Friday, January 29 the stock rating was maintained by UBS with “Buy”. Stifel Nicolaus maintained the stock with “Buy” rating in Friday, April 27 report. On Friday, October 23 the stock rating was upgraded by Bank of America to “Buy”. The firm earned “Neutral” rating on Friday, July 20 by Citigroup.

More notable recent Microsoft Corporation (NASDAQ:MSFT) news were published by: Nasdaq.com which released: “Technology Sector Update for 01/23/2019: IBM, TEL, TDY, MSFT, AAPL, GOOG, CSCO – Nasdaq” on January 23, 2019, also Nasdaq.com with their article: “Technology Sector Update for 01/15/2019: ZIXI, GSIT, RTEC, MSFT, IBM, CSCO, AAPL, GOOG – Nasdaq” published on January 15, 2019, Nasdaq.com published: “Noteworthy ETF Outflows: IWV, MSFT, AAPL, V – Nasdaq” on January 28, 2019. More interesting news about Microsoft Corporation (NASDAQ:MSFT) were released by: Nasdaq.com and their article: “Big Afternoon for Q4 Earnings: FB, MSFT, TSLA, QCOM & V – Nasdaq” published on January 30, 2019 as well as Nasdaq.com‘s news article titled: “Microsoft (MSFT) stock seen as strong buy ahead of second-quarter numbers – Nasdaq” with publication date: January 26, 2019.

Investors sentiment decreased to 0.81 in 2018 Q3. Its down 0.03, from 0.84 in 2018Q2. It worsened, as 33 investors sold MSFT shares while 981 reduced holdings. 145 funds opened positions while 681 raised stakes. 5.28 billion shares or 0.60% less from 5.31 billion shares in 2018Q2 were reported. Gould Asset Mngmt Limited Liability Com Ca accumulated 11,421 shares or 0.52% of the stock. 476,767 were accumulated by Caledonia Public Ltd Liability. Taurus Asset Management Llc holds 256,571 shares. Highlander Cap Mngmt Ltd Co has invested 1.92% in Microsoft Corporation (NASDAQ:MSFT). Parkside Bankshares And Tru holds 0.7% in Microsoft Corporation (NASDAQ:MSFT) or 17,647 shares. Arbor Advsrs Limited Liability Com invested 0.22% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Corvex Mngmt Ltd Partnership holds 1.04 million shares or 5.44% of its portfolio. Welch And Forbes Ltd Liability Com invested in 2.39% or 877,537 shares. First Heartland Consultants stated it has 14,083 shares or 0.5% of all its holdings. Philadelphia reported 419,502 shares. Tennessee-based Capwealth Advsr Ltd Co has invested 4.11% in Microsoft Corporation (NASDAQ:MSFT). Pennsylvania Trust Communication reported 446,103 shares. Oberweis Asset Mngmt Incorporated has 3,770 shares for 0.08% of their portfolio. Seizert Cap Prtn Lc has 1.53% invested in Microsoft Corporation (NASDAQ:MSFT) for 363,604 shares. Meyer Handelman Company has invested 3.65% in Microsoft Corporation (NASDAQ:MSFT).

Third Point Llc, which manages about $17.97B and $14.31 billion US Long portfolio, decreased its stake in S&P Global Inc by 315,100 shares to 984,900 shares, valued at $192.44 million in 2018Q3, according to the filing. It also reduced its holding in Salesforce Com Inc (NYSE:CRM) by 125,000 shares in the quarter, leaving it with 500,000 shares, and cut its stake in Netflix Inc (NASDAQ:NFLX).

Microsoft Corporation (NASDAQ:MSFT) Institutional Positions Chart



Source link